{"id":"https://openalex.org/W2912632549","doi":"https://doi.org/10.1093/cid/ciz710","title":"Erratum to: Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial","display_name":"Erratum to: Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial","publication_year":2019,"publication_date":"2019-10-18","ids":{"openalex":"https://openalex.org/W2912632549","doi":"https://doi.org/10.1093/cid/ciz710","mag":"2912632549","pmid":"https://pubmed.ncbi.nlm.nih.gov/31626688","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7245141"},"language":"en","primary_location":{"id":"doi:10.1093/cid/ciz710","doi":"https://doi.org/10.1093/cid/ciz710","is_oa":true,"landing_page_url":"https://doi.org/10.1093/cid/ciz710","pdf_url":"https://academic.oup.com/cid/article-pdf/70/11/2459/33290502/ciz710.pdf","source":{"id":"https://openalex.org/S72350973","display_name":"Clinical Infectious Diseases","issn_l":"1058-4838","issn":["1058-4838","1537-6591"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"erratum","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://academic.oup.com/cid/article-pdf/70/11/2459/33290502/ciz710.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113451778","display_name":"Thomas M. File","orcid":"https://orcid.org/0009-0009-6080-467X","observed_orcids":["https://orcid.org/0009-0009-6080-467X"]},"institutions":[{"id":"https://openalex.org/I1294639003","display_name":"Summa Health System","ror":"https://ror.org/03p6fpw74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1294639003"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas M File","raw_affiliation_strings":["Summa Health, Akron, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Summa Health, Akron, Ohio","institution_ids":["https://openalex.org/I1294639003"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103872813","display_name":"Lisa Goldberg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lisa Goldberg","raw_affiliation_strings":["Nabriva Therapeutics US, Inc., King of Prussia, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nabriva Therapeutics US, Inc., King of Prussia, Pennsylvania","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102453918","display_name":"Anita Das","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anita Das","raw_affiliation_strings":["Das Consulting, Guerneville, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Das Consulting, Guerneville, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Carolyn Sweeney","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carolyn Sweeney","raw_affiliation_strings":["Nabriva Therapeutics US, Inc., King of Prussia, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nabriva Therapeutics US, Inc., King of Prussia, Pennsylvania","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058825833","display_name":"John Saviski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Saviski","raw_affiliation_strings":["Nabriva Therapeutics US, Inc., King of Prussia, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nabriva Therapeutics US, Inc., King of Prussia, Pennsylvania","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086958262","display_name":"Steven P Gelone","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven P Gelone","raw_affiliation_strings":["Nabriva Therapeutics US, Inc., King of Prussia, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nabriva Therapeutics US, Inc., King of Prussia, Pennsylvania","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032068129","display_name":"Elyse Seltzer","orcid":"https://orcid.org/0000-0002-2672-1266","observed_orcids":["https://orcid.org/0000-0002-2672-1266"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elyse Seltzer","raw_affiliation_strings":["Urogen Pharma, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Urogen Pharma, New York","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079280828","display_name":"Susanne Paukner","orcid":"https://orcid.org/0009-0008-5594-1621","observed_orcids":["https://orcid.org/0009-0008-5594-1621"]},"institutions":[{"id":"https://openalex.org/I4210109875","display_name":"Nabriva Therapeutics (Austria)","ror":"https://ror.org/017ax4r20","country_code":"AT","type":"company","lineage":["https://openalex.org/I4210109875"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Susanne Paukner","raw_affiliation_strings":["Nabriva Therapeutics GmbH, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nabriva Therapeutics GmbH, Vienna, Austria","institution_ids":["https://openalex.org/I4210109875"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011283999","display_name":"Wolfgang W. Wicha","orcid":"https://orcid.org/0000-0002-4863-7559","observed_orcids":["https://orcid.org/0000-0002-4863-7559"]},"institutions":[{"id":"https://openalex.org/I4210109875","display_name":"Nabriva Therapeutics (Austria)","ror":"https://ror.org/017ax4r20","country_code":"AT","type":"company","lineage":["https://openalex.org/I4210109875"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Wolfgang W Wicha","raw_affiliation_strings":["Nabriva Therapeutics GmbH, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nabriva Therapeutics GmbH, Vienna, Austria","institution_ids":["https://openalex.org/I4210109875"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080609948","display_name":"George H. Talbot","orcid":"https://orcid.org/0000-0002-2868-2707","observed_orcids":["https://orcid.org/0000-0002-2868-2707"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"George H Talbot","raw_affiliation_strings":["Talbot Advisors LLC, Anna Maria, Florida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Talbot Advisors LLC, Anna Maria, Florida","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5084081858","display_name":"Leanne B. Gasink","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Leanne B Gasink","raw_affiliation_strings":["Nabriva Therapeutics US, Inc., King of Prussia, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nabriva Therapeutics US, Inc., King of Prussia, Pennsylvania","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4763,"currency":"USD","value_usd":4763},"apc_paid":{"value":4763,"currency":"USD","value_usd":4763},"fwci":null,"has_fulltext":true,"cited_by_count":77,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"70","issue":"11","first_page":"2459","last_page":"2459"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10654","display_name":"Pneumonia and Respiratory Infections","score":0.9667999744415283,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10654","display_name":"Pneumonia and Respiratory Infections","score":0.9667999744415283,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.02280000038444996,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lefamulin","display_name":"lefamulin","score":0.996999979019165},{"id":"https://openalex.org/keywords/pleuromutilin-antibiotics","display_name":"pleuromutilin antibiotics","score":0.9049999713897705},{"id":"https://openalex.org/keywords/community-acquired-bacterial-pneumonia","display_name":"community-acquired bacterial pneumonia","score":0.9810000061988831},{"id":"https://openalex.org/keywords/intravenous-to-oral-switch","display_name":"intravenous to oral switch","score":0.8479999899864197},{"id":"https://openalex.org/keywords/antibiotic-efficacy-and-safety","display_name":"antibiotic efficacy and safety","score":0.8149999976158142},{"id":"https://openalex.org/keywords/conflict-of-interest-disclosure","display_name":"conflict of interest disclosure","score":0.7590000033378601}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9230927228927612},{"id":"https://openalex.org/C2778836808","wikidata":"https://www.wikidata.org/wiki/Q424940","display_name":"Moxifloxacin","level":3,"score":0.8628693222999573},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6310513615608215},{"id":"https://openalex.org/C2781414143","wikidata":"https://www.wikidata.org/wiki/Q411377","display_name":"Linezolid","level":5,"score":0.574190080165863},{"id":"https://openalex.org/C2776345407","wikidata":"https://www.wikidata.org/wiki/Q3776920","display_name":"Bacterial pneumonia","level":3,"score":0.5671559572219849},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5628378391265869},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5590803623199463},{"id":"https://openalex.org/C2777914695","wikidata":"https://www.wikidata.org/wiki/Q12192","display_name":"Pneumonia","level":2,"score":0.5348851084709167},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.48839038610458374},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.4802008867263794},{"id":"https://openalex.org/C2776102371","wikidata":"https://www.wikidata.org/wiki/Q460030","display_name":"Community-acquired pneumonia","level":3,"score":0.4607585072517395},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.43151167035102844},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.4166167676448822},{"id":"https://openalex.org/C2779489039","wikidata":"https://www.wikidata.org/wiki/Q188121","display_name":"Staphylococcus aureus","level":3,"score":0.2197059690952301},{"id":"https://openalex.org/C2778980435","wikidata":"https://www.wikidata.org/wiki/Q424027","display_name":"Vancomycin","level":4,"score":0.12565112113952637},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0688701868057251},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1093/cid/ciz710","doi":"https://doi.org/10.1093/cid/ciz710","is_oa":true,"landing_page_url":"https://doi.org/10.1093/cid/ciz710","pdf_url":"https://academic.oup.com/cid/article-pdf/70/11/2459/33290502/ciz710.pdf","source":{"id":"https://openalex.org/S72350973","display_name":"Clinical Infectious Diseases","issn_l":"1058-4838","issn":["1058-4838","1537-6591"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Infectious Diseases","raw_type":"journal-article"},{"id":"pmid:31626688","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31626688","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7245141","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7245141/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Infect Dis","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/cid/ciz710","doi":"https://doi.org/10.1093/cid/ciz710","is_oa":true,"landing_page_url":"https://doi.org/10.1093/cid/ciz710","pdf_url":"https://academic.oup.com/cid/article-pdf/70/11/2459/33290502/ciz710.pdf","source":{"id":"https://openalex.org/S72350973","display_name":"Clinical Infectious Diseases","issn_l":"1058-4838","issn":["1058-4838","1537-6591"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320306080","display_name":"Foundation for the National Institutes of Health","ror":"https://ror.org/00k86s890"},{"id":"https://openalex.org/F4320318975","display_name":"Nabriva Therapeutics","ror":"https://ror.org/017ax4r20"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2912632549.pdf","grobid_xml":"https://content.openalex.org/works/W2912632549.grobid-xml"},"referenced_works_count":23,"referenced_works":["https://openalex.org/W1550111394","https://openalex.org/W1991909144","https://openalex.org/W2000714505","https://openalex.org/W2065665439","https://openalex.org/W2100922283","https://openalex.org/W2122687703","https://openalex.org/W2132212568","https://openalex.org/W2133979383","https://openalex.org/W2134135813","https://openalex.org/W2135688996","https://openalex.org/W2138455673","https://openalex.org/W2295398066","https://openalex.org/W2338784246","https://openalex.org/W2345894311","https://openalex.org/W2470455431","https://openalex.org/W2484777715","https://openalex.org/W2551731940","https://openalex.org/W2563066297","https://openalex.org/W2577653739","https://openalex.org/W2607163536","https://openalex.org/W2754846640","https://openalex.org/W2773773720","https://openalex.org/W3187555671"],"related_works":["https://openalex.org/W4235175266","https://openalex.org/W6939484915","https://openalex.org/W2985836390","https://openalex.org/W6976869947","https://openalex.org/W2976770987","https://openalex.org/W2901178499","https://openalex.org/W2969746123","https://openalex.org/W3195167849","https://openalex.org/W6939543763","https://openalex.org/W2979143237"],"abstract_inverted_index":{"The":[0,36,118,166],"following":[1],"error":[2],"appeared":[3],"in":[4],"the":[5,30,51,65,97,110,113,116,131,163],"corrected":[6],"proof":[7],"publication":[8],"of":[9,23,32,64,67,69,109,115,130,133,135],"this":[10,169],"article":[11],"[File":[12],"TM,":[13],"Goldberg":[14],"L,":[15],"Das":[16],"A,":[17],"et":[18],"al.":[19],"Efficacy":[20],"and":[21,72,93,100,104,138,159],"Safety":[22],"Intravenous-to-oral":[24],"Lefamulin,":[25],"a":[26,62,128],"Pleuromutilin":[27],"Antibiotic,":[28],"for":[29],"Treatment":[31],"Community-acquired":[33],"Bacterial":[34],"Pneumonia:":[35],"Phase":[37],"III":[38],"Lefamulin":[39],"Evaluation":[40],"Against":[41],"Pneumonia":[42],"(LEAP":[43],"1)":[44],"Trial.":[45],"Clin":[46],"Infect":[47],"Dis":[48],"https://doi.org/10.1093/cid/ciz090]:":[49],"In":[50],"acknowledgement":[52,120],"section,":[53],"it":[54],"currently":[55,61,127],"states":[56],"\u201cG.":[57,123],"H.":[58,124],"T.":[59,125],"is":[60,126],"member":[63,129],"Board":[66,132],"Directors":[68,134],"Nabriva":[70,88,136,154],"Therapeutics":[71,137],"has":[73,139],"received":[74,140],"personal":[75,141],"fees":[76,142],"and/or":[77,143],"other":[78,105,144],"support":[79,145],"from":[80,106,146],"Actelion,":[81,147],"Adynxx,":[82,148],"AN2":[83,149],"Therapeutics,":[84,86,89,91,95,150,152,155,157,161],"Calixa":[85,151],"Meiji-Seika,":[87,153],"Recida":[90,156],"Tripex,":[92,158],"Zavante":[94,160],"outside":[96,162],"submitted":[98,164],"work,":[99],"payments,":[101],"non-financial":[102],"support,":[103],"BioMarkers":[107],"Consortium":[108],"FNIH,":[111],"during":[112],"conduct":[114],"study.\u201d":[117],"correct":[119],"should":[121],"state":[122],"work.\u201d":[165],"publisher":[167],"regrets":[168],"error.":[170]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":15},{"year":2020,"cited_by_count":23},{"year":2019,"cited_by_count":17}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2019-02-21T00:00:00"}